Association of the pretreatment lung immune prognostic index with immune checkpoint inhibitor outcomes in patients with advanced hepatocellular carcinoma.
Tao SunYusheng GuoBo SunLei ChenYanqiao RenLicheng ZhuLijie ZhangYiming LiuChuangsheng ZhengPublished in: European journal of medical research (2023)
Pretreatment LIPI was correlated with worse outcomes for ICIs suggesting that LIPI could be promising biomarker for advanced HCC patients under ICIs.